期刊文献+
任意字段
题名或关键词
题名
关键词
文摘
作者
第一作者
机构
刊名
分类号
参考文献
作者简介
基金资助
栏目信息

颈动脉内中膜厚度检测在老年2型糖尿病中的意义及其影响因素 被引量：3

Carotid Intima-media Thickness and Related Factors in Elderly Patients with Type 2 Diabetes Mellitus
下载PDF
导出
摘要 目的探讨老年2型糖尿病患者颈动脉内中膜厚度(carotid intima-media thickness,CIMT)及其与糖化血红蛋白(HbA1c)、尿酸(UA)、低密度脂蛋白胆固醇(LDL-C)的相关性。方法选择60例老年2型糖尿病患者,其中CIMT增厚组32例,CIMT正常组28例,另取40名健康老年人作为对照组。分别测定CIMT、HbA1c、UA及LDL-C行统计学分析。结果 2型糖尿病CIMT、HbA1c、UA、LDL-C明显高于对照组,2型糖尿病患者中CIMT增厚组较无CIMT增厚组HbA1c、UA升高。相关性分析显示CIMT与HbA1c、UA呈正相关。结论 HbA1c、UA是影响颈动脉CIMT的相关因素,检测这些指标有助于尽早发现糖尿病大血管病变,并协助预测心脑血管疾病发生。 Objective To discuss the correlation between carotid intima-media thickness （CIMT）and glyeosylated hemoglobin（HbAlc）, uric aeid（UA）and low density lipoprotein cholesterol（LDL-C）in elderly patients with type 2 diabetes mellitus（T2DM）. Methods 60 elderly patients with T2DM,including 3Z with thickened CIMT and 28 with non-thickened CIMT, were choosen. Control group consisted of 40 healthy old men. Levels of CIMT, HbAle,UA and LDL-C were examined for statistical analysis. Results Levels of CIMT, HbAIc,UA and LDL-C in T2DM group were higher than that in control group. Levels of HbAlc and UA were higher in thickened-CIMT group than that in non-thickened-CIMT group. CIMT was positively correlated to levels of HbAlc and UA. Conclusions Observation of HbAlc and UA, which are significantly associated with CIMT, will help to detect macrovascular complications in T2DM and facilitate the prediction of cardiovascular and cerebrovascular events.
作者 李秀娟
机构地区 重庆医科大学附属第一医院一分院内分泌科
出处 《成都医学院学报》 CAS 2012年第3期423-425,共3页 Journal of Chengdu Medical College
基金 中国高校医学期刊临床专项资金(NO:11221606)
关键词 颈动脉内中膜厚度 糖尿病 2型 Carotid intima-media thickness Type 2 diabetes mellitus
分类号 R587.1 [医药卫生—内分泌]
  • 相关文献

参考文献17

  • 1Hanefeld M,Koehler C,Schaper F,et al. Postprandial plasma glucose is an independent risk factor for increased carotid intima-media thickness in non-diabetic individuals [J]. Atherosclerosis, 1999,144(1) :229-235.
  • 2Temelkova-Kurktschiev TS, Koehler C, Henkel E, et al. Postchallenge plasma glucose and glycolic spikes are more strongly associated with atherosclerosis than fasting glucose or HbAlc leve[J]. Diabetes Care, 2000,23(12) : 1830-1834.
  • 3Wagenknecht LE, DAgostino RB, Haffner SM, et al. Impaired glucose tolerance, type 2 diabetes, and carotid wall thickness [J]. Diabetes Care,1998,21(11) :1812-1818.
  • 4Lee CD,Folsom AR, Pankow JS, et al. Cardiovascular events in diabetic and nondiabetic adults with or without history of myocardial infarction[J]. Circulation,2004,109(7) :855-860.
  • 5Lorenz MW, Schaefer C, Steinmetz H, et al. Is carotid intima media thickness useful for individual prediction of cardiovascular risk? Ten-year results from the Carotid Atherosclerosis Progression Study(CAPS)[J].Eur Heart J, 2010,31 (16) : 2041-2048.
  • 6Lorenz MW, von Kegler S, Steinmetz H, et al. Carotid intima- media thickening indicates a higher vascular risk aeross a wide age range: prospective data from the Carotid Atherosclerosis Progression Study(CAPS) [J]. Stroke, 2006,37 ( 1 ) :87-92.
  • 7Lee CD, Folsom AR, Pankow JS, et al. Atherosclerosis Risk in Communities (ARIC) Study Investigators. Cardiovascular events in diabetic and nondiabetic adults with or without history of myocardial infarction[J]. Circulation, 2004, 109 (7):855-860.
  • 8Djaberi R, Schuijf JD, de Koning EJ, et al. Usefulness of carotid intima media thickness in patients with diabetes mellitus as a predictor of coronary artery disease[J]. Am J Cardiol, 2009,104 (8):1041-1046.
  • 9Kissela BM, Khoury J, Kleindorfer D, et al. Epidemiology of ischemic stroke in patients with diabetes: the greater Cincinnati/Northern Kentucky Stroke Study [J]. Diabetes Care, 2005,28(2) : 355-359.
  • 10Li C, Engstrom G, Berglund G, et al. Incidence of ischemic stroke in relation to asymptomatie carotid artery atherosclerosis in subjects with normal blood pressure. A prospective cohort study[ J ]. Cerebrovasc Dis, 2008,26 (3) : 297-303.

二级参考文献12

  • 1Heart Outcomes Prevention Evaluation Study Investigators: Effects of ramipril on cardiovascular and microvascular outcomes in people with diabetes mellitus: results of HOPE study and MICRO-HOPE substudy. Lancet, 2000, 355: 253 - 259.
  • 2The HOPE (lteart Outcomes Prevention Evaluation) Study: the design of a large, simple randomized trial of an angiotensin-converting enzyme inhibitor (ramipril) and vitamin E in patients at high risk of cardiovascular events. The HOPE study investigators.
  • 3Lindholm LH, Ibsen H, Dahlof B, et al. Cardiovascular morbidity and mortality in patients with diabetes in the Losartan Intervention For Endpoint reduction in hypertension study ( LIFE ). The Lancet, 2002, 359: 1004 - 1010.
  • 4Scherthaner G. Cardiovascular mortality and morbidity in type-2 diabetes mellitus. Diabetes Res Clin Pract, 1996, 31 ( Suppl ): S3 - S13.
  • 5Bicket DP. Using ACE inhibitors appropriately. Am Fam Physician, 2002, 66:473.
  • 6Kirpichnikov D, Sowers JR. Role of ACE inhibitors in treating hypertensive diabetic patients.Curr Diab Rep, 2002, 2 ( 3 ): 251 - 257.
  • 7Lonn EM, Yusuf S, Jha P, et al. Emerging role of angiotensin-converting enzyme inhibitors incardiac and vascular protection, Circulation, 1994, 90: 2056 - 2069.
  • 8Komers R, Komersova K. Therapeutic potential of ACE inhibitors for the treatment ot hypertension in type 2 diabetes. Expert Opin Investig Drugs, 2000, 9 ( 11 ): 260 - 2617.
  • 9The Expert Committee on the Diagnosis and the Classification of the Diabetes Mellitus: Report of the expert committee on the diagnosis and classification of diabetes mellitus. Diabetes Care,1997, 20: 1183 - 1197.
  • 10Sowers JR, Epstein M, Frohlick ED. Diabetes, hypertension, and cardiovascular disease: anupdate. Hypertension, 2001, 37 ( 4 ): 1053 - 1059.

同被引文献37

引证文献3

二级引证文献19

成都医学院学报
2012年 第3期

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部